Genomic Health, Inc.
(NASDAQ : GHDX)

( )
GHDX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
PROGProgenity, Inc. 19.49%2.820.0%$190.64m
GHGuardant Health, Inc. -2.19%88.710.0%$102.33m
DVADaVita, Inc. 3.31%102.123.8%$98.49m
OSHOak Street Health, Inc. 6.06%30.120.0%$70.76m
NTRANatera, Inc. -0.35%86.261.1%$69.95m
NVTAInvitae Corp. 2.60%15.381.1%$65.00m
AMEDAmedisys, Inc. 5.97%144.4611.4%$57.90m
FLGTFulgent Genetics, Inc. 0.17%81.940.6%$45.80m
ONEM1Life Healthcare, Inc. 11.98%17.290.0%$40.53m
LHCGLHC Group, Inc. 5.88%117.962.9%$39.61m
AGLAgilon Health, Inc. 3.42%22.360.0%$39.41m
CHEChemed Corp. 2.72%482.7710.5%$34.47m
SDCSmileDirectClub, Inc. 5.17%2.850.0%$33.68m
NEONeoGenomics, Inc. 3.67%31.615.1%$26.27m
CANOCano Health, Inc. 5.56%8.920.0%$24.25m

Company Profile

Genomic Health, Inc. (NASDAQ: GHDX) is a provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of massive amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey, from diagnosis to treatment selection and monitoring. The company is based in Redwood City, California, with European headquarters in Geneva, Switzerland.